The Nuchal Translucency (NT) Scan offers an early glimpse into your baby's development, providing valuable information during the first trimester. This screening combines a specific ultrasound measurement with blood markers to help you understand potential risks for certain genetic conditions and structural differences.
What it is
This screening, often called the first trimester combined screening, involves two main components. First, an ultrasound measures the fluid at the back of your baby's neck – this is the nuchal translucency. Second, a blood test analyzes specific markers in your blood, namely PAPP-A (pregnancy-associated plasma protein-A) and free β-hCG (human chorionic gonadotropin). When these two pieces of information are put together, they provide an estimated risk for chromosomal abnormalities, such as Down syndrome, and can also offer early indications of structural defects.
While newer options like NIPT — Cell-Free DNA Screening have largely become the primary screening for chromosomal conditions, the NT scan still offers unique insights. It's particularly useful for identifying potential structural defects, cardiac anomalies, and neural tube concerns that can be visible on ultrasound. Some care providers may even offer the NT scan in conjunction with NIPT for a more comprehensive first-trimester evaluation, giving you a broader picture of your baby's early development. Remember, this is about gathering information to make informed decisions that feel right for you.
